Free Trial

Bioventus (BVS) Stock Price, News & Analysis

$6.90 -0.03 (-0.43%)
As of 02:00 PM Eastern

About Bioventus Stock (NASDAQ:BVS)

Key Stats

Today's Range
$6.77
$7.21
50-Day Range
N/A
52-Week Range
$5.81
$14.38
Volume
220,185 shs
Average Volume
393,978 shs
Market Capitalization
$566.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bioventus Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
21st Percentile Overall Score

BVS MarketRank™: 

Bioventus scored higher than 21% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Bioventus.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Bioventus is -14.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Bioventus is -14.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Bioventus has a P/B Ratio of 3.02. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    3.53% of the float of Bioventus has been sold short.
  • Short Interest Ratio / Days to Cover

    Bioventus has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Bioventus has recently decreased by 2.45%, indicating that investor sentiment is improving.
  • Dividend Yield

    Bioventus does not currently pay a dividend.

  • Dividend Growth

    Bioventus does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.53% of the float of Bioventus has been sold short.
  • Short Interest Ratio / Days to Cover

    Bioventus has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Bioventus has recently decreased by 2.45%, indicating that investor sentiment is improving.
  • News Sentiment

    Bioventus has a news sentiment score of -1.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.13 average news sentiment score of Manufacturing companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Bioventus this week, compared to 0 articles on an average week.
  • Search Interest

    2 people have searched for BVS on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Bioventus to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Bioventus insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    33.00% of the stock of Bioventus is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    62.94% of the stock of Bioventus is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Bioventus' insider trading history.
Receive BVS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioventus and its competitors with MarketBeat's FREE daily newsletter.

BVS Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

BVS Stock Analysis - Frequently Asked Questions

Bioventus' stock was trading at $6.26 on January 1st, 2025. Since then, BVS stock has increased by 10.1% and is now trading at $6.89.

Bioventus Inc. (NASDAQ:BVS) announced its quarterly earnings data on Wednesday, August, 6th. The company reported $0.21 earnings per share for the quarter, missing the consensus estimate of $0.22 by $0.01. Bioventus had a negative net margin of 0.03% and a positive trailing twelve-month return on equity of 23.51%.

Bioventus (BVS) raised $126 million in an IPO on Thursday, February 11th 2021. The company issued 7,400,000 shares at a price of $16.00-$18.00 per share. Morgan Stanley, J.P. Morgan, Goldman Sachs and Canaccord Genuity served as the underwriters for the IPO.

Shares of BVS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/06/2025
Today
8/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Surgical, Medical, And Dental Instruments And Supplies
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BVS
Previous Symbol
NASDAQ:BVS
CIK
1665988
Web
N/A
Fax
N/A
Employees
1,200
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.48)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$33.54 million
Net Margins
-0.03%
Pretax Margin
-8.29%
Return on Equity
23.51%
Return on Assets
5.99%

Debt

Debt-to-Equity Ratio
1.66
Current Ratio
1.43
Quick Ratio
0.89

Sales & Book Value

Annual Sales
$573.28 million
Price / Sales
0.99
Cash Flow
$1.01 per share
Price / Cash Flow
6.81
Book Value
$2.28 per share
Price / Book
3.02

Miscellaneous

Outstanding Shares
82,140,000
Free Float
55,036,000
Market Cap
$565.94 million
Optionable
N/A
Beta
0.83
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:BVS) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners